Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors-Reference-Cited by-同舟云学术

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors

Published:2015-05-27 Issue:3 Volume:1 Page:186-193
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Ayhan Ayse¹²,Mao Tsui‐Lien³,Suryo Rahmanto Yohan¹,Zeppernick Felix¹⁴,Ogawa Hiroshi²,Wu Ren‐Chin¹⁵,Wang Tian‐Li¹,Shih Ie‐Ming¹⁶

Affiliation:

1. Department of PathologyJohns Hopkins Medical InstitutionsBaltimore Maryland

2. Department of PathologyHamamatsu University School of Medicine and Seirei Mikatahara HospitalHamamatsu Japan

3. Department of PathologyNational Taiwan University College of MedicineTaipei Taiwan

4. Department of Gynecology and ObstetricsUniversity Hospital Aachen Germany

5. Department of PathologyChang Gung Memorial Hospital and Chang Gung University College of MedicineTaoyuan Taiwan

6. Department of Gynecology and ObstetricsJohns Hopkins Medical InstitutionsBaltimore Maryland

Funder

DoD-CDMRP

NSC

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.22

Reference23 articles.

1. Integrated genomic characterization of endometrial carcinoma

2. Classification of endometrial carcinoma: more than two types

3. Benign Endometrial Hyperplasia Sequence and Endometrial Intraepithelial Neoplasia

4. Molecular pathology of endometrial carcinoma

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometrial hyperplasia and progesterone resistance: a complex relationship;RUDN Journal of Medicine;2023-03-27

2. ARID1Amutations in cancer development: mechanism and therapy;Carcinogenesis;2023-03-01

3. Molecular typing guiding treatment and prognosis of endometrial cancer;Gynecology and Obstetrics Clinical Medicine;2023-03

4. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma;Facts, Views and Vision in ObGyn;2023-02

5. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis;Modern Pathology;2023-02